Farther Finance Advisors’s Voyager Therapeutics VYGR Stock Holding History

Farther Finance Advisors’s Portfolio VYGR Stock Details VYGR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$236	Buy	88 +74	+529%	+$239	﹤0.01%	5856
2026 Q2	$50	Sell	14 -214	-94%	-$812	﹤0.01%	5854
2026 Q1	$910	Sell	228 -127	-36%	-$500	﹤0.01%	5134
2025 Q4	$1.4K	Hold	355	–	–	﹤0.01%	4813
2025 Q3	$1.66K	Buy	+355	New	+$1.28K	﹤0.01%	4203

Other funds holding VYGR

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

TWD

True Wealth Design Akron, Ohio $426M AUM 16.34% 1-Year Est. Return

Farther Finance Advisors's VYGR Position: Q3 2026 in Review

Farther Finance Advisors increased its Voyager Therapeutics (VYGR) stake by 529% in Q3 2026, buying an estimated $239 and bringing the position to 88 shares worth $236. The position accounts for ﹤0.01% of the portfolio, ranked #5856.

Farther Finance Advisors first reported a position in VYGR in Q3 2025 and has held it in 5 quarters since. The position peaked at $1.66K in Q3 2025. 3 funds tracked by Wall St. Rank hold VYGR as of Q3 2026.

Farther Finance Advisors held 88 shares of Voyager Therapeutics worth $236 as of Q3 2026.
Farther Finance Advisors bought 74 Voyager Therapeutics shares in Q3 2026, an estimated $239.
Voyager Therapeutics made up ﹤0.01% of Farther Finance Advisors's portfolio in Q3 2026, its #5856 holding.
Farther Finance Advisors first reported a position in Voyager Therapeutics in Q3 2025 and has held it in 5 quarters since.
Farther Finance Advisors's Voyager Therapeutics position peaked at $1.66K in Q3 2025.
3 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.